---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-040030"
form_type: "8-K"
ticker: "ADVB"
cik: "0001941029"
company_name: "Advanced Biomed Inc."
filed_at: "2026-04-03T23:59:59+00:00"
generated_at: "2026-05-15T07:39:59.318902+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Advanced Biomed agrees to acquire Acellent Technologies for 270K shares valued at $1.08M

## Summary
- Acquiring 100% of Acellent Technologies (Hong Kong), an AI-powered financial verification company.
- Purchase price: 270,000 shares of ADVB common stock valued at $4.00/share, total $1,080,000.
- Closing subject to completion of due diligence and receipt of regulatory approvals.

## SEC filing metadata
- accession: 0001213900-26-040030
- form_type: 8-K
- ticker: ADVB
- cik: 0001941029
- company_name: Advanced Biomed Inc.
- filed_at: 2026-04-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1941029/000121390026040030/0001213900-26-040030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1941029/000121390026040030/ea0285086-8k_advancedbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-040030
- JSON: https://secwatch.observer/filing/0001213900-26-040030.json
- Plain text: https://secwatch.observer/filing/0001213900-26-040030.txt

## Key facts
- Material Agreements
  Advanced Biomed Inc. entered into Share Purchase Agreement with Acellent Technologies (Hong Kong) Co. Limited and the sole shareholder of the Target valued at 270,000 shares of the Company’s common stock, par value $0.001 per share, with an estimated value of (effective 2026-04-02).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Acellent Technologies (Hong Kong) Co. Limited and the sole shareholder of the Target
  - Value: 270,000 shares of the Company’s common stock, par value $0.001 per share, with an estimated value of
  - Effective: 2026-04-02
  source text: On April 2, 2026, Advanced Biomed Inc. (the “Company”) entered into a Share Purchase Agreement (the “Agreement”) with Acellent Technologies (Hong Kong) Co. Limited (the “Target”) and the sole shareholder of the Target (the “Seller”), pursuant to which the Company agreed to purchase from Seller 100% of the equity interest in the Target (the “Acquisition”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1941029/000121390026040030/0001213900-26-040030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.